Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Biological Replicate ID | Conc Unit | GR50 | GEC50 | GRmax | GRinf | GR Hill Coefficient | GR_AOC | GR r2 | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-175-VII | HR+ | Luminal | Lestaurtinib | FLT3/JAK2/TrkA | RTK | 12126.154 | uM | 0.09697 | 0.41793 | -0.9278 | -0.7819 | 0.6444 | 0.7226 | 0.8237 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | Lestaurtinib | FLT3/JAK2/TrkA | RTK | 10818.154 | uM | 0.65803 | 0.88856 | -0.8282 | -0.3921 | 1.9274 | 0.5051 | 0.8253 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | Lestaurtinib | FLT3/JAK2/TrkA | RTK | 10642.142 | uM | 0.65586 | 1.3130 | -0.8282 | -0.5327 | 1.0450 | 0.5569 | 0.9052 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | Mebendazole | 13754.174 | uM | 0.13250 | 21.1220 | -0.1183 | -1.0000 | 0.2166 | 0.5383 | 0.8916 | 0.4290 | |||
MDA-MB-175-VII | HR+ | Luminal | Methotrexate | DHFR | Metabolism | 7499.084 | uM | inf | inf | 0.8028 | 0.8028 | 0.0000 | 0.0973 | -0.0768 | 0.7991 | |
MDA-MB-175-VII | HR+ | Luminal | Methotrexate | DHFR | Metabolism | 7500.084 | uM | inf | inf | 1.0314 | 1.0314 | 0.0000 | 0.0284 | 0.0671 | 0.5811 | |
MDA-MB-175-VII | HR+ | Luminal | Methylglyoxal | 13676.184 | uM | 458.37740 | 1000.00000 | -0.9929 | -0.6170 | 1.0304 | 0.4458 | 0.8181 | 0.9355 | |||
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 14269.189 | uM | 0.16097 | 0.19121 | -0.9893 | -0.6827 | 5.0000 | 0.8112 | 0.8780 | 0.5173 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 14269.189 | uM | 0.16097 | 0.19121 | -0.9893 | -0.6827 | 5.0000 | 0.8112 | 0.8780 | 0.5173 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 10818.145 | uM | 0.17172 | 0.25805 | -0.9991 | -0.9978 | 2.6938 | 0.8999 | 0.9924 | 0.4621 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 10818.145 | uM | 0.17172 | 0.25805 | -0.9991 | -0.9978 | 2.6938 | 0.8999 | 0.9924 | 0.4621 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 12126.145 | uM | 0.19099 | 0.26765 | -0.9943 | -0.9939 | 3.2434 | 0.8985 | 0.9941 | 0.6493 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 12126.145 | uM | 0.19099 | 0.26765 | -0.9943 | -0.9939 | 3.2434 | 0.8985 | 0.9941 | 0.6493 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 10642.145 | uM | 0.30670 | 0.38133 | -0.9982 | -0.9855 | 5.0000 | 0.8413 | 0.9966 | 0.3537 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 10642.145 | uM | 0.30670 | 0.38133 | -0.9982 | -0.9855 | 5.0000 | 0.8413 | 0.9966 | 0.3537 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 14619.189 | uM | 0.35854 | 0.51258 | -0.8410 | -0.8526 | 2.7843 | 0.7257 | 0.9976 | 1.2787 | |
MDA-MB-175-VII | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 14619.189 | uM | 0.35854 | 0.51258 | -0.8410 | -0.8526 | 2.7843 | 0.7257 | 0.9976 | 1.2787 | |
MDA-MB-175-VII | HR+ | Luminal | Pevonedistat | NAE1 | NAE1 | 12126.135 | uM | 0.31289 | 0.42230 | -0.1996 | -0.1817 | 1.0338 | 0.5180 | 0.9398 | 0.7048 | |
MDA-MB-175-VII | HR+ | Luminal | Pevonedistat | NAE1 | NAE1 | 10642.135 | uM | 0.12059 | 0.45704 | -0.8966 | -0.9086 | 0.7774 | 0.8054 | 0.950 | 0.3509 | |
MDA-MB-175-VII | HR+ | Luminal | Pevonedistat | NAE1 | NAE1 | 10818.148 | uM | 0.25285 | 0.38355 | -0.8018 | -0.6596 | 2.0189 | 0.6696 | 0.9876 | 0.3526 | |
MDA-MB-175-VII | HR+ | Luminal | Nelfinavir | 13754.174 | uM | 6.54890 | 9.60220 | -0.9753 | -1.0000 | 2.8707 | 0.3702 | 0.8599 | 0.4290 | |||
MDA-MB-175-VII | HR+ | Luminal | Nilotinib | ABL | nRTK | 12126.145 | uM | inf | inf | 0.8161 | 0.8161 | 0.0000 | 0.1164 | 0.1697 | 0.6493 | |
MDA-MB-175-VII | HR+ | Luminal | Nilotinib | ABL | nRTK | 10818.145 | uM | inf | 0.93047 | 0.6960 | 0.6936 | 2.0851 | 0.1584 | 0.6048 | 0.4621 | |
MDA-MB-175-VII | HR+ | Luminal | Nilotinib | ABL | nRTK | 10642.145 | uM | 7.49980 | 7.54360 | -0.3759 | -0.0148 | 5.0000 | 0.2756 | 0.8546 | 0.3537 | |
MDA-MB-175-VII | HR+ | Luminal | NSC 663284 | CDC25 | CDC | 10642.14 | uM | 4.82050 | 8.19110 | -0.9997 | -1.0000 | 2.0722 | 0.6033 | 0.9324 | 0.5473 |